Speaking the host language : how Salmonella effector proteins manipulate the host
View/ Open
Date
06/06/2023Author
Keywords
Metadata
Show full item recordAltmetrics Handle Statistics
Altmetrics DOI Statistics
Abstract
Salmonella injects over 40 virulence factors, termed effectors, into host cells to subvert diverse host cellular processes. Of these 40 Salmonella effectors, at least 25 have been described as mediating eukaryotic-like, biochemical post-translational modifications (PTMs) of host proteins, altering the outcome of infection. The downstream changes mediated by an effector’s enzymatic activity range from highly specific to multifunctional, and altogether their combined action impacts the function of an impressive array of host cellular processes, including signal transduction, membrane trafficking, and both innate and adaptive immune responses. Salmonella and related Gram-negative pathogens have been a rich resource for the discovery of unique enzymatic activities, expanding our understanding of host signalling networks, bacterial pathogenesis as well as basic biochemistry. In this review, we provide an up-to-date assessment of host manipulation mediated by the Salmonella type III secretion system injectosome, exploring the cellular effects of diverse effector activities with a particular focus on PTMs and the implications for infection outcomes. We also highlight activities and functions of numerous effectors that remain poorly characterized.
Citation
Pillay , T D , Hettiarachchi , S U , Gan , J , Diaz-Del-Olmo , I , Yu , X J , Muench , J H , Thurston , T L M & Pearson , J S 2023 , ' Speaking the host language : how Salmonella effector proteins manipulate the host ' , Microbiology , vol. 169 , no. 6 , 001342 . https://doi.org/10.1099/mic.0.001342
Publication
Microbiology
Status
Peer reviewed
ISSN
1350-0872Type
Journal item
Rights
© 2023 The Authors. This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/).
Description
Funding: T.L.M.T. is supported by a Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship (BB/R011834/1) and a Medical Research Council (MRC) Research Grant MR/V031058/1, which also funds I.D.D.O. and J.M. This work was also supported by the Francis Crick Institute which receives its core funding from Cancer Research United Kingdom (CC 2075), the United Kingdom Medical Research Council (CC 2075), and the Wellcome Trust (CC 2075) to T.D.P. J.S.P. is supported by a Sylvia and Charles Viertel Senior Medical Research Fellowship (SMRF22008).Collections
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.